Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  General Electric Company    GE

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

General Electric Company : GE & Partners Announce Winners of the First Stage of $100 Million "healthymagination Cancer Challenge"

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/27/2012 | 04:10pm CET

  • Challenge focused on early-stage breast cancer breakthroughs that warrant discovery, incubation and acceleration through seed funding
  • Winning innovations could expedite breast cancer detection, diagnosis and improve the identification of effective therapies, allowing more patients to survive

GE (NYSE: GE) announced today five innovation award winners as part of the first stage of its $100 million "GE healthymagination Cancer Challenge." More than 500 ideas from 40 countries were submitted, sparking robust conversations among more than 200 academic institutions and researchers on the Challenge's open innovation platform.

The five innovation award winners have the potential to help doctors find cancer earlier, make more accurate diagnoses and choose the best possible treatment based on each patient's unique cancer. The submitted ideas include ones that could help doctors better understand the molecular similarities between breast cancer and other solid tumors with a particular focus on tumors associated with triple negative cancer, a type of cancer that is less responsive to standard treatments and is typically more aggressive. GE is committed to a new approach at healthymagination that shines a spotlight on early-stage ideas to accelerate the researchers' work and ultimately help patients sooner.

Beth Comstock, senior vice president and chief marketing officer, GE said, "We launched the Challenge as a call to action for oncology researchers, businesses, and other innovators around the world to accelerate innovation and help stop this deadly disease. It is often challenging for early stage research to grab the attention of seed investors. The Challenge has shown us that there are a remarkable number of breakthrough ideas out there that deserve promotion, investment and incubation."

In addition to the $100,000 seed award, GE will provide support for each winner through mentorship and access to GE researchers and industry thought leaders with opportunity for expanded partnerships in the future.

"GE and Clarient focus on helping health providers understand and define the drivers of a patient's particular cancer. The Challenge winners' work will change the future of fighting cancer," said Carrie Eglinton-Manner, general manager of Clarient, the cancer diagnostics company acquired by GE in 2010. "In addition to the grant money, we will help mentor, develop and accelerate the growth of these winning ideas."

The winners were selected by a panel of judges that included venture capital partners, GE executives, and several leading healthcare luminaries including former U.S. FDA Commissioner and National Cancer Institute Director, Dr. Andrew Von Eschenbach; Professor of Surgery and Director of the University of Michigan Breast Care Center, Dr. Lisa Newman; and cancer medicine specialist and Imperial College's professor of cancer medicine, Dr. Justin Stebbing.

The five innovation Challenge award winners are:

  • MyCancerGenome- Personalized Approach to Triple Negative Breast Cancer: Vanderbilt University in Nashville, Tennessee is developing MyCancerGenome, a free online cancer medicine resource and decision-making tool for physicians, patients, caregivers and researchers. It provides up-to-date information on what mutations make breast cancer grow and related treatment implications, including available genome-directed clinical trials for triple negative breast cancer.
  • Creating Safer & Stronger Breast Implants with Cancer-fighting and Healing Properties: The University of Akron in Akron, Ohio is developing new materials for breast reconstruction to transform tissue expanders and implants into cancer-fighting and healing devices. Using coatings embedded with pharmaceutical agents the new device is expected to help fight infection, reduce inflammation, and possibly even target and destroy stray cancer cells.
  • Identifying a Predisposition to Cancer Spread: Moffitt Cancer Center in Tampa, Florida is working to understand the genetic "modifier" genes and their role in predisposition to the spread of cancer to other parts of the body following cancer onset. This research could form the basis of diagnostic testing for genes that place a patient at disproportionate risk for cancer spread and guide aggressiveness of treatment.
  • Saving Lives in Developing Countries: For developing countries such as Uganda, breast ultrasound holds promise in identifying cancers in young women with palpable lumps. Fred Hutchinson Cancer Research Center in Seattle, Washington and Uganda Cancer Institute (UCI) in Kampala are establishing a breast cancer screening program where women will receive education about breast cancer and those with symptoms will be offered clinical breast exam and breast ultrasound. Women with suspicious lumps will be referred to the UCI for tissue sampling and, if malignancy is diagnosed, treatment.
  • Moving to Personalized Therapy for Triple Negative Breast Cancer: Researchers at Vanderbilt-Ingram Cancer Center in Nashville, Tennessee have demonstrated that gene expression analysis reveals at least six distinct disease subtypes for triple negative breast cancer that likely respond differently to chemotherapy. Using this discovery, the Center is designing clinical trials with targeted therapy for select subtypes which will soon be offered to patients.

Information on the winners is available at www.healthymagination.com.

Launched in September, the Challenge is part of GE's healthymagination commitment to accelerate cancer innovation by investing $1 billion in cancer technology research and development as well as improve care for 10 million cancer patients around the world by 2020. Additional strategic commercial partnership announcements from the Challenge will be made later in 2012. For additional details on the challenge, and to view the full terms and conditions visit healthymagination.com/challenge.

About GE

GE (NYSE: GE) works on things that matter. The best people and the best technologies taking on the toughest challenges. Finding solutions in energy, health and home, transportation and finance. Building, powering, moving and helping to cure the world. Not just imagining. Doing. GE works. For more information, visit the company's website at www.ge.com.

About GE's healthymagination Initiative

Launched in May 2009, GE's healthymagination initiative is focused on four critical needs: low-cost technology; healthcare IT; innovation accessible to all; and consumer-driven healthcare. GE has committed that by 2015 it will:

  • Invest $3 billion in research and development to launch at least 100 innovations that will help deliver better care to more people at lower cost.
  • Provide $2 billion in financing and $1 billion in technology to bring healthcare information technology to rural and underserved areas.
  • Reduce the cost of procedures that use GE technologies and services by 15 percent and develop products tailored to underserved regions of the world.
  • Reach 100 million more people every year with services and technologies essential for health.

More information at www.healthymagination.com.

GE
Megan Parker, 203-373-2020
Megan.Parker@ge.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on GENERAL ELECTRIC COMPANY
03:20p GENERAL ELECTRIC : FG plans rail, road link for Jos dry port
01:30p ENI : UK export agency signs first loan deal in Africa for Ghana energy project
12:34p GENERAL ELECTRIC : Bahrain's Alba Places Order for GE's World-Record-Setting HA ..
12:01p GENERAL ELECTRIC : Bahrain’s Alba Places Order for GE’s World-Record..
04:22a TRANSPORT : FG plans rail, road link to Jos ICD 
04:22a TRANSPORT : FG plans rail, road link for Jos dry port
01/14 GENERAL ELECTRIC : Capital Insight Partners Cuts Position in General Electric Co..
01/14 GENERAL ELECTRIC : MILITARY $69,764 Federal Contract Awarded to G.E. Aviation
01/14 GENERAL ELECTRIC : Woodstock Corp Lowers stake in General Electric Company
01/13DJGENERAL ELECTRIC : GE's Tax Team Heads to PwC -- 4th Update
More news
Sector news : Industrial Conglomerates
01/13 Centrica completes exit from wind power with Lincs wind farm sale
01/13 KKR to buy Hitachi's power tools unit for $1.3 billion
01/12 Bayer says had productive meeting with Trump over Monsanto deal
01/12 SIEMENS : CVC Capital in the lead to acquire MSC Software - sources
01/11 France to buy out Areva shareholders in bid for nuclear fix
More sector news : Industrial Conglomerates
News from SeekingAlpha
07:37a Game Plan For The Week - Cramer's Mad Money (1/13/17)
03:25a General Electric's Q4 2016 Earnings Preview, The 3 Things To Watch For
01/13 Pentair, Roper upgraded at J.P. Morgan on Trump effect; GE a "top avoid"
01/13 UNITED TECHNOLOGIES : Muddy Short-Term Future, Long-Term Promise
01/13 GENERAL ELECTRIC : Strap Yourselves In, It's Going To Be A Wild Ride
Advertisement
Financials ($)
Sales 2016 124 262 M
EBIT 2016 18 728 M
Net income 2016 12 511 M
Debt 2016 79 625 M
Yield 2016 3,00%
P/E ratio 2016 26,80
P/E ratio 2017 20,21
EV / Sales 2016 2,87x
EV / Sales 2017 2,42x
Capitalization 277 423 M
More Financials
Chart GENERAL ELECTRIC COMPANY
Duration : Period :
General Electric Company Technical Analysis Chart | GE | US3696041033 | 4-Traders
Full-screen chart
Technical analysis trends GENERAL ELECTRIC ...
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 34,3 $
Spread / Average Target 9,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey R. Immelt Chairman & Chief Executive Officer
Shane Fitzsimons Senior Vice President-Global Operations
Jeffrey S. Bornstein Chief Financial Officer & Senior Vice President
Jim Fowler Chief Information Officer
Victor Abate Chief Technology Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GENERAL ELECTRIC COMPA..-0.76%277 423
3M CO-0.66%106 694
SIEMENS AG-0.34%105 271
HONEYWELL INTERNATIONA..1.92%89 984
E I DU PONT DE NEMOURS..0.27%63 984
ILLINOIS TOOL WORKS IN..0.76%43 310
More Results